Literature DB >> 8516302

Residues crucial for Ras interaction with GDP-GTP exchangers.

M Segal1, B M Willumsen, A Levitzki.   

Abstract

Cdc25 is essential for Ras-mediated activation of adenylyl cyclase in the yeast Saccharomyces cerevisiae. This protein acts by catalyzing GDP-GTP exchange on yeast Ras. Harvey (Ha) ras expressed in S. cerevisiae is also recognized by both Cdc25 and Sdc25, a yeast homolog of Cdc25. Thus it is feasible to examine molecular aspects of mammalian Ras modulation by Cdc25 using the RAS/cAMP pathway in yeast as a model system. Here, we describe mutational analysis of Ha-ras for the identification of residues critical for the ability of Ras to interact with Cdc25 and related guanine nucleotide-release proteins. Mutations within codons 97-108 impaired Ras-mediated activation of adenylyl cyclase in the presence but not in the absence of mammalian GTPase-activating protein. Such mutations, therefore, affected the ability of Ras to undergo GDP-GTP exchange catalyzed by the guanine nucleotide exchanger without preventing Ras activation of the effector. Similar mutations were previously shown to impair the ability of c-ras to transform mammalian cells while having a less drastic effect on v-ras.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8516302      PMCID: PMC46761          DOI: 10.1073/pnas.90.12.5564

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 2.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Regulatory function of the Saccharomyces cerevisiae RAS C-terminus.

Authors:  M S Marshall; J B Gibbs; E M Scolnick; I S Sigal
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.

Authors:  H Adari; D R Lowy; B M Willumsen; C J Der; F McCormick
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

5.  Functional homology of mammalian and yeast RAS genes.

Authors:  T Kataoka; S Powers; S Cameron; O Fasano; M Goldfarb; J Broach; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

6.  In yeast, RAS proteins are controlling elements of adenylate cyclase.

Authors:  T Toda; I Uno; T Ishikawa; S Powers; T Kataoka; D Broek; S Cameron; J Broach; K Matsumoto; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

7.  Phosphorylation of the S. cerevisiae Cdc25 in response to glucose results in its dissociation from Ras.

Authors:  E Gross; D Goldberg; A Levitzki
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

8.  Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments.

Authors:  D Botstein; S C Falco; S E Stewart; M Brennan; S Scherer; D T Stinchcomb; K Struhl; R W Davis
Journal:  Gene       Date:  1979-12       Impact factor: 3.688

9.  Mammalian and yeast ras gene products: biological function in their heterologous systems.

Authors:  D DeFeo-Jones; K Tatchell; L C Robinson; I S Sigal; W C Vass; D R Lowy; E M Scolnick
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

10.  Expression of normal and activated human Ha-ras cDNAs in Saccharomyces cerevisiae.

Authors:  S G Clark; J P McGrath; A D Levinson
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  9 in total

1.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

Authors:  Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D Logsdon
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Distinct subclasses of small GTPases interact with guanine nucleotide exchange factors in a similar manner.

Authors:  G J Day; R D Mosteller; D Broek
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 3.  Targeting signal transduction for disease therapy.

Authors:  A Levitzki
Journal:  Med Oncol       Date:  1997-06       Impact factor: 3.064

4.  A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.

Authors:  Karen W Gripp; Eugenia Bifeld; Deborah L Stabley; Elizabeth Hopkins; Stefanie Meien; Kathy Vinette; Katia Sol-Church; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2012-07-20       Impact factor: 2.802

5.  Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors.

Authors:  L A Quilliam; K Kato; K M Rabun; M M Hisaka; S Y Huff; S Campbell-Burk; C J Der
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

6.  Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus.

Authors:  N Hurwitz; M Segal; I Marbach; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 7.  40 Years of RAS-A Historic Overview.

Authors:  Alberto Fernández-Medarde; Javier De Las Rivas; Eugenio Santos
Journal:  Genes (Basel)       Date:  2021-05-01       Impact factor: 4.096

8.  Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.

Authors:  S R Lin; C H Hsu; J H Tsai; J Y Wang; T J Hsieh; C H Wu
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders.

Authors:  Maria Rita Gulotta; Riccardo Brambilla; Ugo Perricone; Andrea Brancale
Journal:  Pharmaceuticals (Basel)       Date:  2021-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.